{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:04:27Z","timestamp":1648620267794},"reference-count":4,"publisher":"Elsevier BV","issue":"9396","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/s0140-6736(03)14809-x","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T13:04:02Z","timestamp":1069333442000},"page":"1676","source":"Crossref","is-referenced-by-count":0,"title":["The CHARM programme"],"prefix":"10.1016","volume":"362","author":[{"given":"MG","family":"Gama","sequence":"first","affiliation":[]},{"given":"G","family":"Rocha","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(03)14809-X_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)14809-X_bib2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin- receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)14809-X_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0735-1097(01)01715-6","article-title":"Neurohormonal blockade in chronic heart failure: how much is enough? Can there be too much?","volume":"39","author":"Massie","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(03)14809-X_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067360314809X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067360314809X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T23:41:57Z","timestamp":1531525317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067360314809X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":4,"journal-issue":{"issue":"9396","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S014067360314809X"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(03)14809-x","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}